Damora Therapeutics logo
Damora Therapeutics
GLTO | NASDAQ
Chart Builder DCF Calculator
$21.58
-$0.75 (-3.36%)
At close: Jun 4, 2026, 12:02 PM ET

Damora Therapeutics Cash Flow Statement

Cash flow statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
-209.84M -21.44M -38.35M -61.62M -51.75M -34.84M
34K 181K 830K 490K 441K 188K
998K 3.24M 5.43M 5.57M 4.48M 982K
18.31M -1.34M -2.72M 10.12M -5.3M -4.11M
183.72M 2.06M -449K 694K 75K 55K
– – – – 1.07M –
18.36M -2.67M -4.37M 11.94M -6.62M -4.59M
-6.73M -18.62M -36.91M -42.93M -52.31M -38.2M
– – – -196K -223K –
– – – 70K 47.83K –
-17.37M – -25.94M -44.87M -84.21M –
– 11.65M 48.18M 57.45M 36.38M –
– – 83K -70K -47.83K –
-17.37M 11.65M 22.33M 12.38M -48.05M –
– – – – – –
– – – – – –
– – – – – –
– – – – – -4.95M
266.84M – 2.88M 507K – 187.39M
243.45M -7.29M -11.32M -29.78M -101.27M 152.31M
-6.73M -18.62M -36.91M -43.13M -52.53M -38.2M
-7.72M -21.86M -42.34M -48.7M -57.01M -39.19M
– – – -196K -223K –
– – – – – –
-6.73M -18.62M -36.91M -43.13M -52.53M -38.2M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.